Health Care M&A Deals, Week Ending January 18, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price MEDIAN 2 addiction treatment clinics in Germany N/A Biotechnology Acquirer Target Price Apricus Biosciences, Inc. Seelos Therapeutics, Inc. N/A Celgene Corporation License to cell therapies N/A eHealth Acquirer Target Price PerfectServe... Read More »
Health Care M&A Deals, Week Ending January 11, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Eli Lilly and Company Loxo Oncology, Inc. $8,000,000,000 Knight Therapeutics Inc. Exclusive rights to commercialize Nerlynx $7,200,000 eHealth Acquirer Target Price Medici Chiron Health N/A ZOLL Medical Corporation Payor... Read More »
Q4:18 Health Care Dollar Volume Was Just … Robust
Deal volume has climbed higher every year since 2012. Spending on those deals hasn’t been as predictable, which is why we watch deal volume more closely. But dollar signs attract attention, so here is where the preliminary results point. Combined spending in 2018 now stands at $330.3 billion and may rise slightly higher as we uncover more prices. The total is 21% higher than 2017’s $311.6 billion, but doesn’t come close to the $387.7 billion spent in 2014. That was the year Actavis plc (now NYSE: AGN) paid $66 billion for Allergan plc; Medtronic plc (NYSE: MDT) paid $42.9 billion for Covidien; and Actavis (then NYSE: ACT) acquired Forrest Laboratories for $25.0 billion. That year saw... Read More »
Q4:18 Health Care Deal Volume: Strong End to a Strong Year
It’s broken record time. Every January for the past six years, we’ve led with a story that says the previous year broke the record for healthcare deal volume. Why break a streak? More than 1,850 healthcare deals were announced in 2018, 14% more than in 2017 and by far the most we’ve ever reported. It may be repetitive, but consider the alternative. The fourth quarter of 2018 clocked in with 461 deals, a preliminary total for sure, but very solid performance. The total was only 1% behind the third quarter’s total of 466 transactions, and it beat the 2017 Q4 total by 16%. The Long-Term Care sector was the busiest, with 97 deals recorded so far. Despite the troubles affecting the sector’s... Read More »
Health Care M&A Deals, Week Ending January 4, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price The Columbus Organization Support Associates of Tampa Bay N/A Biotechnology Acquirer Target Price Bristol-Myers Squibb Company Celgene Corporation $74,000,000,000 Merck & Co., Inc. License to proprietary influenza A/B antiviral agents N/A... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
